Outpatient Oncology Infusion Market Report 2026
Outpatient Oncology Infusion Market Global Report 2026 Market Report Infographic Image

Published : March 2026

Pages : 250

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Outpatient Oncology Infusion Market Report 2026

Global Outlook – By Product (Infusion Pumps, Intravenous Sets, Intravenous Cannulas, Needleless Connectors), By Therapy (Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy), By Application (Lung Cancer, Liver Cancer, Breast Cancer, Prostate Cancer, Other Cancers), By End-User (Hospitals, Outpatient Clinics, Home Care Settings) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Outpatient Oncology Infusion Market Overview

• Outpatient Oncology Infusion market size has reached to $14.02 billion in 2025

• Expected to grow to $20.21 billion in 2030 at a compound annual growth rate (CAGR) of 7.5%

• Growth Driver: Increasing Prevalence Of Cancer Cases Driving The Growth Of The Market Due To Aging Populations And Rising Cancer Risk

• Market Trend: Advancements In Smart Infusion Technology For Improved Safety And Efficiency

North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Outpatient Oncology Infusion Market?

Outpatient oncology infusion refers to the administration of cancer-fighting medications to patients in a non-hospital setting, such as infusion centers or clinics. Its purpose is to provide effective, convenient, and cost-efficient cancer treatment while allowing patients to avoid lengthy hospital stays.

The main product types of outpatient oncology infusion include infusion pumps, intravenous sets, intravenous cannulas, and needleless connectors. Infusion pumps are medical devices used to deliver controlled amounts of fluids, such as medications or nutrients, into a patient’s body over a specific period. These devices provide various therapies such as chemotherapy, targeted therapy, immunotherapy, and hormonal therapy. They are used in different applications, including lung cancer, liver cancer, breast cancer, prostate cancer, and others, and by various end users such as hospitals, outpatient clinics, and home care settings.

Outpatient Oncology Infusion Market Global Report 2026 Market Report bar graph

What Is The Outpatient Oncology Infusion Market Size and Share 2026?

The outpatient oncology infusion market size has grown strongly in recent years. It will grow from $14.02 billion in 2025 to $15.12 billion in 2026 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period can be attributed to increasing cancer prevalence rates, expansion of outpatient oncology infrastructure, adoption of infusion-based therapies, improved survival rates requiring ongoing treatment, availability of advanced infusion devices.

What Is The Outpatient Oncology Infusion Market Growth Forecast?

The outpatient oncology infusion market size is expected to see strong growth in the next few years. It will grow to $20.21 billion in 2030 at a compound annual growth rate (CAGR) of 7.5%. The growth in the forecast period can be attributed to increasing demand for precision oncology treatments, rising investments in outpatient infusion centers, expansion of home-compatible infusion technologies, growing focus on cost-efficient cancer care, increasing integration of digital oncology monitoring. Major trends in the forecast period include increasing shift toward outpatient cancer treatment models, rising adoption of targeted and immunotherapies, growing use of smart infusion pumps, expansion of ambulatory infusion centers, enhanced focus on patient-centric oncology care.

Customer representative image Book your 30 minutes free consultation with our research experts

Global Outpatient Oncology Infusion Market Segmentation

1) By Product: Infusion Pumps, Intravenous Sets, Intravenous Cannulas, Needleless Connectors

2) By Therapy: Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy

3) By Application: Lung Cancer, Liver Cancer, Breast Cancer, Prostate Cancer, Other Cancers

4) By End-User: Hospitals, Outpatient Clinics, Home Care Settings

Subsegments:

1) By Infusion Pumps: Volumetric Infusion Pumps, Syringe Infusion Pumps, Elastomeric Infusion Pumps, Ambulatory Infusion Pumps, Smart Infusion Pumps

2) By Intravenous Sets: Vented IV Sets, Non-Vented IV Sets, Gravity IV Sets, Pump-Compatible IV Sets, Filtered IV Sets

3) By Intravenous Cannulas: Peripheral IV Cannulas, Central IV Cannulas, Winged IV Cannulas (Butterfly), Closed IV Cannulas, Safety IV Cannulas

4) By Needleless Connectors: Positive Displacement Connectors, Negative Displacement Connectors, Neutral Displacement Connectors, Closed System Transfer Devices (CSTDs), Anti-Reflux Connectors

What Is The Driver Of The Outpatient Oncology Infusion Market?

The increasing prevalence of cancer cases is expected to propel the growth of the outpatient oncology infusion market going forward. Cancer is a group of complex diseases marked by the uncontrolled growth of abnormal cells, which can invade surrounding tissues and spread to other areas of the body. The prevalence of cancer cases is increasing primarily due to aging populations worldwide, as the risk of developing cancer rises significantly with age. Outpatient oncology infusion is used to administer cancer treatments such as chemotherapy, immunotherapy, or targeted therapy in a clinical setting without requiring hospital admission, allowing patients to receive care while maintaining their daily routines. For instance, in April 2024, according to Macmillan Cancer Support, a UK-based charity providing practical, emotional, and financial support to people affected by cancer, it is projected that the number of individuals living with cancer in the UK will exceed 3 million presently, reaching 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. Therefore, the increasing prevalence of cancer cases is driving the growth of the outpatient oncology infusion industry.

Key Players In The Global Outpatient Oncology Infusion Market

Major companies operating in the outpatient oncology infusion market are Medtronic plc, Becton Dickinson and Company, Baxter International Inc., Fresenius Kabi AG, Terumo Corporation, Nipro Corporation, Smiths Medical Inc., ICU Medical Inc., B. Braun Melsungen AG, InfuSystem Holdings Inc., BPL Medical Technologies Private Limited, Angiplast Private Limited, Bio-Med Healthcare Products Private Limited, Lars Medicare Private Limited, Micrel Medical Devices S.A., AKAS Infusions Private Limited, Mais India Medical Devices Private Limited, Wellead Medical Co. Ltd., AdvaCare Pharma USA LLC, Polymed Medical Devices Private Limited.

Global Outpatient Oncology Infusion Market Trends and Insights

Major companies operating in the outpatient oncology infusion market are focusing on technological advancement in infusion systems, such as next-generation smart infusion pumps to enhance medication safety and streamline chemotherapy delivery. Next-generation smart infusion pumps refer to digitally connected devices with advanced dose-error reduction software, integrated drug libraries, and real-time connectivity to minimize errors and standardize oncology treatments. For instance, in April 2024, Baxter International Inc., a US-based medical technology company, received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Novum IQ large-volume infusion pump, making it available for U.S. ordering. The integrated hardware-software system delivers precise large-volume infusions with embedded safety checks, dose-library enforcement, and connectivity for remote management. Baxter highlights advanced safety architecture, improved usability, and compatibility with its broader infusion ecosystem. The pump is suited for outpatient oncology infusion centers, ambulatory clinics, and hospitals, offering benefits such as enhanced dosing accuracy, streamlined nursing workflows, and reduced delays or adverse events during chemotherapy administration.

Need data on a specific region in this market?

What Are Latest Mergers And Acquisitions In The Outpatient Oncology Infusion Market?

In December 2024, Cardinal Health, a US-based healthcare products, services, and distribution company, acquired Integrated Oncology Network (ION) for an undisclosed amount. With this acquisition, Cardinal Health aims to expand its specialty-care footprint by integrating ION’s more than 50 community-based oncology and urology practice sites across 10 U.S. states into its oncology alliance network, thereby enhancing its service offerings, broadening provider reach, and strengthening value-based care delivery across the cancer care continuum. Integrated Oncology Network is a US-based healthcare network that delivers a full spectrum of oncology and urology care, including medical oncology, radiation oncology, diagnostic testing, surgical oncology, and ancillary services, through its community-based practice sites.

Regional Outlook

North America was the largest region in the outpatient oncology infusion market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Outpatient Oncology Infusion Market?

The outpatient oncology infusion market consists of revenues earned by entities by providing services such as hormone therapy infusions, supportive care infusions, patient monitoring, patient education, and counseling. The market value includes the value of related goods sold by the service provider or included within the service offering. The outpatient oncology infusion market also includes sales of biosimilars, immunotherapy agents, supportive care drugs, infusion bags, IV poles, and stands. Values in this market are ‘factory gate’ values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Outpatient Oncology Infusion Market Report 2026?

The outpatient oncology infusion market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the outpatient oncology infusion industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Outpatient Oncology Infusion Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $15.12 billion
Revenue Forecast In 2035 $20.21 billion
Growth Rate CAGR of 7.8% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Product, Therapy, Application, End-User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Medtronic plc, Becton Dickinson and Company, Baxter International Inc., Fresenius Kabi AG, Terumo Corporation, Nipro Corporation, Smiths Medical Inc., ICU Medical Inc., B. Braun Melsungen AG, InfuSystem Holdings Inc., BPL Medical Technologies Private Limited, Angiplast Private Limited, Bio-Med Healthcare Products Private Limited, Lars Medicare Private Limited, Micrel Medical Devices S.A., AKAS Infusions Private Limited, Mais India Medical Devices Private Limited, Wellead Medical Co. Ltd., AdvaCare Pharma USA LLC, Polymed Medical Devices Private Limited.
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Outpatient Oncology Infusion Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Outpatient Oncology Infusion Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Outpatient Oncology Infusion Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Outpatient Oncology Infusion Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Artificial Intelligence & Autonomous Intelligence

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Increasing Shift Toward Outpatient Cancer Treatment Models

4.2.2 Rising Adoption Of Targeted And Immunotherapies

4.2.3 Growing Use Of Smart Infusion Pumps

4.2.4 Expansion Of Ambulatory Infusion Centers

4.2.5 Enhanced Focus On Patient-Centric Oncology Care

5. Outpatient Oncology Infusion Market Analysis Of End Use Industries

5.1 Cancer Patients

5.2 Oncology Clinics

5.3 Ambulatory Infusion Centers

5.4 Hospitals

5.5 Home Care Oncology Patients

6. Outpatient Oncology Infusion Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Outpatient Oncology Infusion Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Outpatient Oncology Infusion PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Outpatient Oncology Infusion Market Size, Comparisons And Growth Rate Analysis

7.3. Global Outpatient Oncology Infusion Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Outpatient Oncology Infusion Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Outpatient Oncology Infusion Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Outpatient Oncology Infusion Market Segmentation

9.1. Global Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Infusion Pumps, Intravenous Sets, Intravenous Cannulas, Needleless Connectors

9.2. Global Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy

9.3. Global Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Lung Cancer, Liver Cancer, Breast Cancer, Prostate Cancer, Other Cancers

9.4. Global Outpatient Oncology Infusion Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Outpatient Clinics, Home Care Settings

9.5. Global Outpatient Oncology Infusion Market, Sub-Segmentation Of Infusion Pumps, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Volumetric Infusion Pumps, Syringe Infusion Pumps, Elastomeric Infusion Pumps, Ambulatory Infusion Pumps, Smart Infusion Pumps

9.6. Global Outpatient Oncology Infusion Market, Sub-Segmentation Of Intravenous Sets, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Vented IV Sets, Non-Vented IV Sets, Gravity IV Sets, Pump-Compatible IV Sets, Filtered IV Sets

9.7. Global Outpatient Oncology Infusion Market, Sub-Segmentation Of Intravenous Cannulas, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Peripheral IV Cannulas, Central IV Cannulas, Winged IV Cannulas (Butterfly), Closed IV Cannulas, Safety IV Cannulas

9.8. Global Outpatient Oncology Infusion Market, Sub-Segmentation Of Needleless Connectors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Positive Displacement Connectors, Negative Displacement Connectors, Neutral Displacement Connectors, Closed System Transfer Devices (CSTDs), Anti-Reflux Connectors

10. Outpatient Oncology Infusion Market Regional And Country Analysis

10.1. Global Outpatient Oncology Infusion Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Outpatient Oncology Infusion Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Outpatient Oncology Infusion Market

11.1. Asia-Pacific Outpatient Oncology Infusion Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Outpatient Oncology Infusion Market, Segmentation By Product, Segmentation By Therapy, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Outpatient Oncology Infusion Market

12.1. China Outpatient Oncology Infusion Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Outpatient Oncology Infusion Market, Segmentation By Product, Segmentation By Therapy, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Outpatient Oncology Infusion Market

13.1. India Outpatient Oncology Infusion Market, Segmentation By Product, Segmentation By Therapy, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Outpatient Oncology Infusion Market

14.1. Japan Outpatient Oncology Infusion Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Outpatient Oncology Infusion Market, Segmentation By Product, Segmentation By Therapy, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Outpatient Oncology Infusion Market

15.1. Australia Outpatient Oncology Infusion Market, Segmentation By Product, Segmentation By Therapy, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Outpatient Oncology Infusion Market

16.1. Indonesia Outpatient Oncology Infusion Market, Segmentation By Product, Segmentation By Therapy, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Outpatient Oncology Infusion Market

17.1. South Korea Outpatient Oncology Infusion Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Outpatient Oncology Infusion Market, Segmentation By Product, Segmentation By Therapy, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Outpatient Oncology Infusion Market

18.1. Taiwan Outpatient Oncology Infusion Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Outpatient Oncology Infusion Market, Segmentation By Product, Segmentation By Therapy, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Outpatient Oncology Infusion Market

19.1. South East Asia Outpatient Oncology Infusion Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Outpatient Oncology Infusion Market, Segmentation By Product, Segmentation By Therapy, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Outpatient Oncology Infusion Market

20.1. Western Europe Outpatient Oncology Infusion Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Outpatient Oncology Infusion Market, Segmentation By Product, Segmentation By Therapy, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Outpatient Oncology Infusion Market

21.1. UK Outpatient Oncology Infusion Market, Segmentation By Product, Segmentation By Therapy, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Outpatient Oncology Infusion Market

22.1. Germany Outpatient Oncology Infusion Market, Segmentation By Product, Segmentation By Therapy, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Outpatient Oncology Infusion Market

23.1. France Outpatient Oncology Infusion Market, Segmentation By Product, Segmentation By Therapy, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Outpatient Oncology Infusion Market

24.1. Italy Outpatient Oncology Infusion Market, Segmentation By Product, Segmentation By Therapy, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Outpatient Oncology Infusion Market

25.1. Spain Outpatient Oncology Infusion Market, Segmentation By Product, Segmentation By Therapy, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Outpatient Oncology Infusion Market

26.1. Eastern Europe Outpatient Oncology Infusion Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Outpatient Oncology Infusion Market, Segmentation By Product, Segmentation By Therapy, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Outpatient Oncology Infusion Market

27.1. Russia Outpatient Oncology Infusion Market, Segmentation By Product, Segmentation By Therapy, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Outpatient Oncology Infusion Market

28.1. North America Outpatient Oncology Infusion Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Outpatient Oncology Infusion Market, Segmentation By Product, Segmentation By Therapy, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Outpatient Oncology Infusion Market

29.1. USA Outpatient Oncology Infusion Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Outpatient Oncology Infusion Market, Segmentation By Product, Segmentation By Therapy, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Outpatient Oncology Infusion Market

30.1. Canada Outpatient Oncology Infusion Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Outpatient Oncology Infusion Market, Segmentation By Product, Segmentation By Therapy, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Outpatient Oncology Infusion Market

31.1. South America Outpatient Oncology Infusion Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Outpatient Oncology Infusion Market, Segmentation By Product, Segmentation By Therapy, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Outpatient Oncology Infusion Market

32.1. Brazil Outpatient Oncology Infusion Market, Segmentation By Product, Segmentation By Therapy, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Outpatient Oncology Infusion Market

33.1. Middle East Outpatient Oncology Infusion Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Outpatient Oncology Infusion Market, Segmentation By Product, Segmentation By Therapy, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Outpatient Oncology Infusion Market

34.1. Africa Outpatient Oncology Infusion Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Outpatient Oncology Infusion Market, Segmentation By Product, Segmentation By Therapy, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Outpatient Oncology Infusion Market Regulatory and Investment Landscape

36. Outpatient Oncology Infusion Market Competitive Landscape And Company Profiles

36.1. Outpatient Oncology Infusion Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Outpatient Oncology Infusion Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Outpatient Oncology Infusion Market Company Profiles

36.3.1. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Fresenius Kabi AG Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis

37. Outpatient Oncology Infusion Market Other Major And Innovative Companies

Nipro Corporation, Smiths Medical Inc., ICU Medical Inc., B. Braun Melsungen AG, InfuSystem Holdings Inc., BPL Medical Technologies Private Limited, Angiplast Private Limited, Bio-Med Healthcare Products Private Limited, Lars Medicare Private Limited, Micrel Medical Devices S.A., AKAS Infusions Private Limited, Mais India Medical Devices Private Limited, Wellead Medical Co. Ltd., AdvaCare Pharma USA LLC, Polymed Medical Devices Private Limited

38. Global Outpatient Oncology Infusion Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Outpatient Oncology Infusion Market

40. Outpatient Oncology Infusion Market High Potential Countries, Segments and Strategies

40.1 Outpatient Oncology Infusion Market In 2030 - Countries Offering Most New Opportunities

40.2 Outpatient Oncology Infusion Market In 2030 - Segments Offering Most New Opportunities

40.3 Outpatient Oncology Infusion Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Outpatient Oncology Infusion Market, Overview Of Key Products - Product Examples
  • Table 2: Global Outpatient Oncology Infusion Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Outpatient Oncology Infusion Market, Supply Chain Analysis
  • Table 4: Global Outpatient Oncology Infusion Market, Major Raw Material Providers
  • Table 5: Global Outpatient Oncology Infusion Market, Major Resource Providers
  • Table 6: Global Outpatient Oncology Infusion Market, Major Manufacturers (Suppliers)
  • Table 7: Global Outpatient Oncology Infusion Market, Major Distributors And Channel Partners
  • Table 8: Global Outpatient Oncology Infusion Market, Key Technologies & Future Trends
  • Table 9: Global Outpatient Oncology Infusion Market, Major Trends
  • Table 10: Global Outpatient Oncology Infusion Market, Major End Users
  • Table 11: Global Outpatient Oncology Infusion Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Outpatient Oncology Infusion Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Outpatient Oncology Infusion Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Outpatient Oncology Infusion Market - TAM, US$ Billion, 2025
  • Table 15: Global Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Outpatient Oncology Infusion Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Outpatient Oncology Infusion Market, Sub-Segmentation Of Infusion Pumps, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Outpatient Oncology Infusion Market, Sub-Segmentation Of Intravenous Sets, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Outpatient Oncology Infusion Market, Sub-Segmentation Of Intravenous Cannulas, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Outpatient Oncology Infusion Market, Sub-Segmentation Of Needleless Connectors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Outpatient Oncology Infusion Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Global Outpatient Oncology Infusion Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Asia-Pacific, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Asia-Pacific, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: Asia-Pacific, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: China, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: China, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: China, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: India, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: India, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: India, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Japan, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Japan, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Japan, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Australia, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Australia, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Australia, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Indonesia, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Indonesia, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: Indonesia, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: South Korea, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: South Korea, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: South Korea, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Taiwan, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Taiwan, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: Taiwan, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: South East Asia, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: South East Asia, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: South East Asia, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Western Europe, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Western Europe, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: Western Europe, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: UK, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: UK, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: UK, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Germany, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Germany, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: Germany, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: France, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: France, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: France, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Italy, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Italy, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Italy, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Spain, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Spain, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Spain, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Eastern Europe, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Eastern Europe, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Eastern Europe, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Russia, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Russia, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: Russia, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: North America, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: North America, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: North America, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: USA, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: USA, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: USA, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: Canada, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: Canada, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: Canada, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: South America, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: South America, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: South America, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Brazil, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Brazil, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Brazil, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Middle East, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Middle East, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Middle East, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Africa, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Africa, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Africa, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 97: Global Outpatient Oncology Infusion Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 98: Global Outpatient Oncology Infusion Market - Company Scoring Matrix
  • Table 99: Medtronic plc Financial Performance
  • Table 100: Becton Dickinson and Company Financial Performance
  • Table 101: Baxter International Inc. Financial Performance
  • Table 102: Fresenius Kabi AG Financial Performance
  • Table 103: Terumo Corporation Financial Performance
  • Table 104: Global Outpatient Oncology Infusion Market, Competitive Benchmarking (In USD Billions)
  • Table 105: Global Outpatient Oncology Infusion Market, Competitive Dashboard
  • Table 106: Global Outpatient Oncology Infusion Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 107: Global, Outpatient Oncology Infusion Market Size Gain ($ Billion), Segmentation By Product, 2025 – 2030
  • Table 108: Global, Outpatient Oncology Infusion Market Size Gain ($ Billion), Segmentation By Therapy, 2025 – 2030
  • Table 109: Global, Outpatient Oncology Infusion Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

List Of Figures

    Figure 1: Global Outpatient Oncology Infusion Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Outpatient Oncology Infusion Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Outpatient Oncology Infusion Market, Supply Chain Analysis
  • Figure 4: Global Outpatient Oncology Infusion Market, Major Raw Material Providers
  • Figure 5: Global Outpatient Oncology Infusion Market, Major Resource Providers
  • Figure 6: Global Outpatient Oncology Infusion Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Outpatient Oncology Infusion Market, Major Distributors And Channel Partners
  • Figure 8: Global Outpatient Oncology Infusion Market, Key Technologies & Future Trends
  • Figure 9: Global Outpatient Oncology Infusion Market, Major Trends
  • Figure 10: Global Outpatient Oncology Infusion Market, Major End Users
  • Figure 11: Global Outpatient Oncology Infusion Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Outpatient Oncology Infusion Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Outpatient Oncology Infusion Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Outpatient Oncology Infusion Market - TAM, US$ Billion, 2025
  • Figure 15: Global Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Outpatient Oncology Infusion Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Outpatient Oncology Infusion Market, Sub-Segmentation Of Infusion Pumps, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Outpatient Oncology Infusion Market, Sub-Segmentation Of Intravenous Sets, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Outpatient Oncology Infusion Market, Sub-Segmentation Of Intravenous Cannulas, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Outpatient Oncology Infusion Market, Sub-Segmentation Of Needleless Connectors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Outpatient Oncology Infusion Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Global Outpatient Oncology Infusion Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Asia-Pacific, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Asia-Pacific, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: Asia-Pacific, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: China, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: China, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: China, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: India, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: India, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: India, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Japan, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Japan, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Japan, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Australia, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Australia, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Australia, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Indonesia, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Indonesia, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: Indonesia, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: South Korea, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: South Korea, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: South Korea, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Taiwan, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Taiwan, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: Taiwan, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: South East Asia, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: South East Asia, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: South East Asia, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Western Europe, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Western Europe, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: Western Europe, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: UK, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: UK, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: UK, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Germany, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Germany, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: Germany, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: France, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: France, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: France, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Italy, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Italy, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Italy, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Spain, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Spain, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Spain, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Eastern Europe, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Eastern Europe, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Eastern Europe, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Russia, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Russia, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: Russia, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: North America, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: North America, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: North America, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: USA, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: USA, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: USA, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: Canada, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: Canada, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: Canada, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: South America, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: South America, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: South America, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Brazil, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Brazil, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Brazil, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Middle East, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Middle East, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Middle East, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Africa, Outpatient Oncology Infusion Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Africa, Outpatient Oncology Infusion Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Africa, Outpatient Oncology Infusion Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 97: Global Outpatient Oncology Infusion Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 98: Global Outpatient Oncology Infusion Market - Company Scoring Matrix
  • Figure 99: Medtronic plc Financial Performance
  • Figure 100: Becton Dickinson and Company Financial Performance
  • Figure 101: Baxter International Inc. Financial Performance
  • Figure 102: Fresenius Kabi AG Financial Performance
  • Figure 103: Terumo Corporation Financial Performance
  • Figure 104: Global Outpatient Oncology Infusion Market, Competitive Benchmarking (In USD Billions)
  • Figure 105: Global Outpatient Oncology Infusion Market, Competitive Dashboard
  • Figure 106: Global Outpatient Oncology Infusion Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 107: Global, Outpatient Oncology Infusion Market Size Gain ($ Billion), Segmentation By Product, 2025 – 2030
  • Figure 108: Global, Outpatient Oncology Infusion Market Size Gain ($ Billion), Segmentation By Therapy, 2025 – 2030
  • Figure 109: Global, Outpatient Oncology Infusion Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

Frequently Asked Questions

The Outpatient Oncology Infusion market was valued at $14.02 billion in 2025, increased to $15.12 billion in 2026, and is projected to reach $20.21 billion by 2030.

The global Outpatient Oncology Infusion market is expected to grow at a CAGR of 7.5% from 2026 to 2035 to reach $20.21 billion by 2035.

Some Key Players in the Outpatient Oncology Infusion market Include, Medtronic plc, Becton Dickinson and Company, Baxter International Inc., Fresenius Kabi AG, Terumo Corporation, Nipro Corporation, Smiths Medical Inc., ICU Medical Inc., B. Braun Melsungen AG, InfuSystem Holdings Inc., BPL Medical Technologies Private Limited, Angiplast Private Limited, Bio-Med Healthcare Products Private Limited, Lars Medicare Private Limited, Micrel Medical Devices S.A., AKAS Infusions Private Limited, Mais India Medical Devices Private Limited, Wellead Medical Co. Ltd., AdvaCare Pharma USA LLC, Polymed Medical Devices Private Limited. .

Major trend in this market includes: Advancements In Smart Infusion Technology For Improved Safety And Efficiency. For further insights on this market. request a sample here

North America was the largest region in the outpatient oncology infusion market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the outpatient oncology infusion market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts